Pacific Biosciences of California, Inc.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2016 | $53.2M | $137.9M | $16.8M |
| FY2017 | $58.0M | $144.1M | $16.5M |
| FY2018 | $56.2M | $170.3M | $18.8M |
| FY2019 | $93.1M | $148.0M | $29.6M |
| FY2020 | $78.5M | $414.0M | $81.6M |
| FY2021 | $1.22B | $2.01B | $460.7M |
| FY2022 | $1.20B | $1.77B | $325.1M |
| FY2023 | $1.04B | $1.75B | $179.9M |
| FY2024 | $753.9M | $1.26B | $55.4M |
| FY2025 | $778.7M | $784.1M | $63.7M |